p16 Expression Differentiates High-Risk Gastrointestinal Stromal Tumor and Predicts Poor Outcome

Por Schmieder, Michael, Wolf, Sebastian, Danner, Bettina, Stoehr, Susanne, Juchems, Markus S, Wuerl, Peter, Henne-Bruns, Doris, Knippschild, Uwe, Hasel, Cornelia, Kramer, Klaus
Publicado em 2008

DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinoma

Por Ettrich, Thomas J., Perkhofer, Lukas, von Wichert, Goetz, Gress, Thomas M., Michl, Patrick, Hebart, Holger F., Büchner-Steudel, Petra, Geissler, Michael, Muche, Rainer, Danner, Bettina, Kächele, Volker, Berger, Andreas W., Güthle, Melanie, Seufferlein, Thomas
Publicado no BMC Cancer (2016)